-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 19, 2021, BlueRock (BlueRock Therapeutics), a clinical trial stage biopharmaceutical company wholly-owned by the Bayer Group, announced that the U.
The FDA’s fast-track qualification is designed to promote the development and speed up the approval process of new therapies for treating serious diseases and filling unmet medical needs
The trial will recruit 10 patients in the United States and Canada
Note: The original text has been deleted